Quarry LP’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8K Sell
60
-584
-91% -$113K ﹤0.01% 877
2025
Q4
$112K Buy
644
+365
+131% +$66.5K 0.02% 406
2025
Q3
$53.2K Buy
279
+170
+156% +$30.2K 0.01% 809
2025
Q2
$19.6K Sell
109
-358
-77% -$62.2K ﹤0.01% 1191
2025
Q1
$79K Sell
467
-738
-61% -$121K 0.02% 613
2024
Q4
$182K Buy
1,205
+826
+218% +$128K 0.03% 271
2024
Q3
$58.8K Sell
379
-162
-30% -$24.2K 0.01% 647
2024
Q2
$74.1K Buy
+541
New +$74.1K 0.02% 471
2024
Q1
Sell
-224
Closed -$30.9K 1698
2023
Q4
$30.9K Buy
224
+51
+29% +$6.71K ﹤0.01% 526
2023
Q3
$21.1K Buy
+173
New +$23.1K ﹤0.01% 665

Other funds holding DGX

Quarry LP's DGX Position: Q1 2026 in Review

Quarry LP reduced its Quest Diagnostics (DGX) stake by 91% in Q1 2026, selling an estimated $113K and leaving 60 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Quarry LP first reported a position in DGX in Q3 2023 and has held it in 10 quarters since. The position peaked at $182K in Q4 2024. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Quarry LP held 60 shares of Quest Diagnostics worth $11.8K as of Q1 2026.
  • Quarry LP sold 584 Quest Diagnostics shares in Q1 2026, an estimated $113K.
  • Quest Diagnostics made up ﹤0.01% of Quarry LP's portfolio in Q1 2026, its #877 holding.
  • Quarry LP first reported a position in Quest Diagnostics in Q3 2023 and has held it in 10 quarters since.
  • Quarry LP's Quest Diagnostics position peaked at $182K in Q4 2024.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.